EDITORIALS

Can Biology Trump Anatomy? Do All Node-Positive Patients With Breast Cancer Need Chemotherapy?

N. Lynn Henry and Daniel F. Hayes

JCO Jun 20 2007: 2501–2503. [Full Text] [PDF] [Hungarian PDF] [Chinese PDF]

Can Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Be Overcome by Different Small-Molecule Tyrosine Kinase Inhibitors?

Paul A. Bunn, Jr

JCO Jun 20 2007: 2504–2505. [Full Text] [PDF]

Regulatory T Lymphocytes: Pivotal Components of the Host Antitumor Response

Evgeny Yakirevich and Murray B. Resnick

JCO Jun 20 2007: 2506–2508. [Full Text] [PDF]

ORIGINAL REPORTS
Breast Cancer
	Leuprorelin Acetate Every-3-Months Depot Versus Cyclophosphamide, Methotrexate, and Fluorouracil As Adjuvant Treatment in Premenopausal Patients With Node-Positive Breast Cancer: The TABLE Study
	Peter Schmid, Michael Untch, Valentin Kossé, Grigorij Bondar, Leonid Vassiljev, Valerie Tarutinov, Ute Lehmann, Lutz Maubach, Juergen Meurer, Diethelm Wallwiener, and Kurt Possinger
	JCO Jun 20 2007: 2509–2515. [Abstract] [Full Text] [PDF] [Hungarian PDF] [Chinese PDF]
	Lost Opportunities: Physicians' Reasons and Disparities in Breast Cancer Treatment
	Nina A. Bickell, Felice LePar, Jason J. Wang, and Howard Leventhal
	JCO Jun 20 2007: 2516–2521. [Abstract] [Full Text] [PDF]
	Social and Racial Differences in Selection of Breast Cancer Adjuvant Chemotherapy Regimens
	Jennifer J. Griggs, Eva Culakova, Melony E.S. Sorbero, Marek S. Poniewierski, Debra A. Wolff, Jeffrey Crawford, David C. Dale, and Gary H. Lyman
	JCO Jun 20 2007: 2522–2527. [Abstract] [Full Text] [PDF]

Lung Cancer
	Phase II Study of Erlotinib in Advanced Non–Small-Cell Lung Cancer After Failure of Gefitinib
	Byoung Chul Cho, Chong-Kun Im, Moo-Suk Park, Se Kyu Kim, Joon Chang, Jong Pil Park, Hye Jin Choi, Yu Jin Kim, Sang-Joon Shin, Joo Hyuk Sohn, Hoguen Kim, and Joo Hang Kim
	JCO Jun 20 2007: 2528–2533. [Abstract] [Full Text] [PDF] [Chinese PDF]
	Prognostic Significance of 99mTc Hynic-rh-Annexin V Scintigraphy During Platinum-Based Chemotherapy in Advanced Lung Cancer
	Marina Kartachova, Nico van Zandwijk, Sjaak Burgers, Harm van Tinteren, Marcel Verheij, and Renato Alfredo Valdés Olmos
	JCO Jun 20 2007: 2534–2539. [Abstract] [Full Text] [PDF]

Melanoma
	Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma
	Malcolm Ranson, Peter Hersey, Damien Thompson, Jane Beith, Grant A. McArthur, Andrew Haydon, Ian D. Davis, Richard F. Kefford, Peter Mortimer, Peter A. Harris, Sofia Baka, Augustus Seebaran, Ami Sabharwal, Amanda J. Watson, Geoffrey P. Margison, and Mark R. Middleton
	JCO Jun 20 2007: 2540–2545. [Abstract] [Full Text] [PDF]
	Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine
	Paola Filipazzi, Roberta Valenti, Veronica Huber, Lorenzo Pilla, Paola Canese, Manuela Iero, Chiara Castelli, Luigi Mariani, Giorgio Parmiani, and Licia Rivoltini
	JCO Jun 20 2007: 2546–2553. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up
	Ama Z.S. Rohatiner, Lee Nadler, Andrew J. Davies, John Apostolidis, Donna Neuberg, Janet Matthews, John G. Gribben, Peter M. Mauch, T. Andrew Lister, and Arnold S. Freedman
	JCO Jun 20 2007: 2554–2559. First published on May 21 2007; 10.1200/JCO.2006.09.8327. [Abstract] [Full Text] [PDF] [Polish PDF]

Supportive Care and Quality of Life
	Age, Health, and Education Determine Supportive Care Needs of Men Younger Than 70 Years With Prostate Cancer
	David P. Smith, Rajah Supramaniam, Madeleine T. King, Jeanette Ward, Martin Berry, and Bruce K. Armstrong
	JCO Jun 20 2007: 2560–2566. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Gemcitabine, Cisplatin, and Radiotherapy for Patients With Locally Advanced Pancreatic Adenocarcinoma: Results of the North Central Cancer Treatment Group Phase II Study N9942
	Michael G. Haddock, Revathi Swaminathan, Nathan R. Foster, Mark D. Hauge, James A. Martenson, John K. Camoriano, Philip J. Stella, Richard C. Tenglin, Paul L. Schaefer, Dennis F. Moore, Jr, and Steven R. Alberts
	JCO Jun 20 2007: 2567–2572. [Abstract] [Full Text] [PDF]
	Identifying Stage III Colorectal Cancer Patients: The Influence of the Patient, Surgeon, and Pathologist
	Eva Judith Ann Morris, Nicola Joanne Maughan, David Forman, and Philip Quirke
	JCO Jun 20 2007: 2573–2579. [Abstract] [Full Text] [PDF] [Hungarian PDF]
	Weekly Infusional High-Dose Fluorouracil (HD-FU), HD-FU Plus Folinic Acid (HD-FU/FA), or HD-FU/FA Plus Biweekly Cisplatin in Advanced Gastric Cancer: Randomized Phase II Trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie
	Manfred P. Lutz, Hansjochen Wilke, D.J. Theo Wagener, Udo Vanhoefer, Krzysztof Jeziorski, Susanna Hegewisch-Becker, Leopold Balleisen, Eric Joossens, Rob L. Jansen, Muriel Debois, Ullrich Bethe, Michel Praet, Jacques Wils, and Eric Van Cutsem
	JCO Jun 20 2007: 2580–2585. [Abstract] [Full Text] [PDF]
	Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
	Qiang Gao, Shuang-Jian Qiu, Jia Fan, Jian Zhou, Xiao-Ying Wang, Yong-Sheng Xiao, Yang Xu, Yi-Wei Li, and Zhao-You Tang
	JCO Jun 20 2007: 2586–2593. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	UGT1A1 Promoter Genotype Correlates With SN-38 Pharmacokinetics, but Not Severe Toxicity in Patients Receiving Low-Dose Irinotecan
	Clinton F. Stewart, John C. Panetta, Melinda A. O'Shaughnessy, Stacy L. Throm, Charles H. Fraga, Thandranese Owens, Tiebin Liu, Catherine Billups, Carlos Rodriguez-Galindo, Amar Gajjar, Wayne L. Furman, and Lisa M. McGregor
	JCO Jun 20 2007: 2594–2600. [Abstract] [Full Text] [PDF]

Neurooncology
	Prognostic Factors for Survival in Adult Patients With Recurrent Glioma Enrolled Onto the New Approaches to Brain Tumor Therapy CNS Consortium Phase I and II Clinical Trials
	Kathryn A. Carson, Stuart A. Grossman, Joy D. Fisher, and Edward G. Shaw
	JCO Jun 20 2007: 2601–2606. [Abstract] [Full Text] [PDF] [Spanish PDF]

REVIEW ARTICLE
	Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
	Asma Sultana, Catrin Tudur Smith, David Cunningham, Naureen Starling, John P. Neoptolemos, and Paula Ghaneh
	JCO Jun 20 2007: 2607–2615. [Abstract] [Full Text] [PDF] [Polish PDF] [Russian PDF] [Chinese PDF]

DIAGNOSIS IN ONCOLOGY

Spontaneous Pneumothorax in Metastatic Thyroid Papillary Carcinoma

Mi-Jung Lee, Eun-Kyung Kim, Min Jung Kim, Jin Young Kwak, SoonWon Hong, and Cheong Soo Park

JCO Jun 20 2007: 2616–2618. [Full Text] [PDF]

Pathological Complete Response in Triple Negative Poorly Differentiated Invasive Ductal Breast Carcinoma Detected During Pregnancy

Garima Agrawal, Jeon Hor Chen, Choong Hyun Baick, Antony Eugene Chen, Rita S. Mehta, Orhan Nalcioglu, and Min-Ying Su

JCO Jun 20 2007: 2618–2620. [Full Text] [PDF]

Paraneoplastic Polyarthritis From Non–Small-Cell Lung Cancer Metastatic to the Bladder

Trinity J. Bivalacqua, Hannah Alphs, Ivan Aksentijevich, Edward M. Schaeffer, and Mark P. Schoenberg

JCO Jun 20 2007: 2621–2623. [Full Text] [PDF]

CORRESPONDENCE

Testing the Efficacy of Antiangiogenic Agents in Advanced Neuroendocrine Tumors

Miquel Beltran-Fabregat, Montserrat Velasco-Capellas, and Javier A. Menendez

JCO Jun 20 2007: 2624. [Full Text] [PDF]

In Reply

Matthew H. Kulke and Charles S. Fuchs

JCO Jun 20 2007: 2624-a–2625. [Full Text] [PDF]

Transplantation in Childhood Very High Risk Acute Lymphoblastic Leukemia in First Complete Remission: Where Are We Now?

Adriana Balduzzi, Valentino Conter, Cornelio Uderzo, and Maria Grazia Valsecchi

JCO Jun 20 2007: 2625–2626. [Full Text] [PDF]

In Reply

Josep-Maria Ribera, Juan-José Ortega, and Albert Oriol

JCO Jun 20 2007: 2627–2628. [Full Text] [PDF]

CD4+CD25highFOXP3+ Regulatory T Cells in Peripheral Blood Are Primarily of Effector Memory Phenotype

Marc Beyer and Joachim L. Schultze

JCO Jun 20 2007: 2628–2630. [Full Text] [PDF]

In Reply

Giovanni Cesana and Howard L. Kaufman

JCO Jun 20 2007: 2630–2632. [Full Text] [PDF]

Does the Search for Large Genomic Rearrangements Impact BRCAPRO Carrier Prediction?

Carlo Capalbo, Amelia Buffone, Annarita Vestri, Enrico Ricevuto, Christian Rinaldi, Massimo Zani, Sergio Ferraro, Luigi Frati, Isabella Screpanti, Alberto Gulino, and Giuseppe Giannini

JCO Jun 20 2007: 2632–2634. [Full Text] [PDF]

In Reply

Giovanni Parmigiani and Donald A. Berry

JCO Jun 20 2007: 2634–2635. [Full Text] [PDF]

Many New Cancer Drugs in the United Kingdom Are Facing Negative NICE Rulings

Eric Low

JCO Jun 20 2007: 2635–2636. [Full Text] [PDF]

In Reply

Michael F. Drummond and Anne R. Mason

JCO Jun 20 2007: 2637–2738. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.